AstraZeneca announced that it has entered into an agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, under...
AstraZeneca announced it has entered into a commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for...
Prilocaine hydrochloride is indicated in adults and children aged above 6 months as a local anaesthetic for use in infiltration anaesthesia and nerve blocks.
For the treatment of chronic constipation in children 1 to 11 years of age. For the treatment of faecal impaction in children from the age of 5 years, defined as refractory constipation with faecal loading of the rectum and/or colon.
Used topically to provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated with deficient tear production. (Usually in cases of rheumatoid arthritis, keratoconjunctivitis sicca and xerophthalmia). Also used as an ocular lubricant for artificial eyes.
Laxido Paediatric Plain is indicated for the treatment of chronic constipation in children aged 1 to 11 years. Laxido Paediatric Plain is indicated for the treatment of faecal impaction in children from the age of 5 years, defined as refractory constipation with faecal loading of the rectum and/or colon.
For the treatment of chronic constipation. For resolving faecal impaction. Faecal impaction is defined as refractory constipation with faecal loading in the rectum and/or colon confirmed by physical or radiological examination of the abdomen and rectum.